Key Insights

Highlights

Success Rate

92% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

2.4%

1 terminated out of 42 trials

Success Rate

92.3%

+5.8% vs benchmark

Late-Stage Pipeline

14%

6 trials in Phase 3/4

Results Transparency

8%

1 of 12 completed with results

Key Signals

1 with results92% success

Data Visualizations

Phase Distribution

29Total
Not Applicable (15)
P 1 (2)
P 2 (6)
P 3 (1)
P 4 (5)

Trial Status

Unknown13
Completed12
Recruiting10
Not Yet Recruiting4
Active Not Recruiting2
Terminated1

Trial Success Rate

92.3%

Benchmark: 86.5%

Based on 12 completed trials

Clinical Trials (42)

Showing 20 of 20 trials
NCT07202559Not ApplicableRecruiting

Indometacin With or Without Aggressive Intravenous Hydration to Prevent Pancreatitis After Pancreatic Extracorporeal Shock Wave Lithotripsy

NCT07244432RecruitingPrimary

Post-ERCP Pancreatitis - Prophylactic Measures Implementation Study (PEP-PROMIS)

NCT05160506Phase 2Recruiting

Corticosteroids to Treat Pancreatitis

NCT06126601Recruiting

Incidence and Clinical Impact of Serum Hyperamylasemia (POH) After Pancreatectomy on Postoperative Outcome and Patient Safety

NCT03609944Not ApplicableCompleted

SpHincterotomy for Acute Recurrent Pancreatitis

NCT07267169Not ApplicableNot Yet RecruitingPrimary

Efferon LPS Hemoadsorption in Patients With Acute Pancreatitis

NCT07171112Phase 2Recruiting

Smoking Cessation Trial in Recurrent Acute Pancreatitis and Chronic Pancreatitis

NCT07168863RecruitingPrimary

EUS-guided FNB-induced PANCREatitis Assessment

NCT07024199Phase 4RecruitingPrimary

Comparison of the Effectiveness of Paracetamol With Ibuprofen or Paracetamol With Metamizole in Treating Pain in Acute Pancreatitis in Children

NCT05350371Phase 1RecruitingPrimary

Safety and Tolerability of Pirfenidone in Acute Pancreatitis

NCT05381428Phase 3CompletedPrimary

Prophylaxis of Post-ERCP Acute Pancreatitis

NCT06729996Phase 2Recruiting

Pioglitazone Versus Empagliflozin for Chronic Pancreatitis/Recurrent Acute Pancreatitis Associated Diabetes Mellitus

NCT06972238Not Yet RecruitingPrimary

Glucose Levels in Acute Pancreatitis and the Impact of Insulin Depletion and Bacterial Endotoxaemia

NCT04760847Not ApplicableNot Yet Recruiting

Intermittent Fasting for Pancreatitis

NCT06706440Completed

The Study of the Natural Way of Development of External Pancreatic Fistulas in Children with Necrotizing Pancreatitis

NCT06623513Phase 2Not Yet RecruitingPrimary

Efficacy and Safety of Parecoxib vs. Indomethacin in Preventing Post-ERCP Pancreatitis

NCT04966559Phase 2Active Not RecruitingPrimary

Effects of a Peripherally Acting µ-opioid Receptor Antagonist on Recurrent Acute Pancreatitis

NCT04570852Not ApplicableCompletedPrimary

Acute Pancreatitis Targets (APT) Study

NCT05572788Not ApplicableUnknown

Rectal Indomethacin to Prevent Acute Pancreatitis in EUS-FNA of Pancreatic Cysts

NCT06178172Not ApplicableUnknownPrimary

Remote Home Monitoring in Mild Acute Pancreatitis

Scroll to load more

Research Network

Activity Timeline